Thorsten Oliver Goetze, Arndt Vogel, Maria A. Gonzalez-Carmona, Timorshah Habibzada, Johanna Reinecke, Marius Adler, Daniel Pink, Thomas Jens Ettrich, Christoph Roderburg, Ursula Pession, Anna Lena Saborowski, Florian van Boemmel, Thomas Wehler, Claus-Henning Koehne, Marina Schaaf, Disorn Sookthai, Regina Eickhoff, Miriam Pons, Salah-Eddin Al-Batran, Dominik Paul Modest. "ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer—The IKF/AIO-ADJUBIL trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4132